FindTrial
Sign In

Efficacy and safety trial of intraperitoneal furosemide in patients on peritoneal dialysis

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519356-87-00
Enrollment
37
Registered
2025-03-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dialysis Heart failure

Brief summary

efficiency and safety measures, reduction in body fluid volume, weight, blood preasure, presence of oedema, bioimpedance values, ultrasound values (venous excess ultrasound score, VEXUS, and lung ultrasound), biochemical markers of congestion: CA125 and NT-proBNP

Detailed description

other measures of interest, Increased diuresis: 24-hour urine volume, 24-hour urine sodium

Interventions

DRUGFUROSEMIDE SODIUM

Sponsors

Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
efficiency and safety measures, reduction in body fluid volume, weight, blood preasure, presence of oedema, bioimpedance values, ultrasound values (venous excess ultrasound score, VEXUS, and lung ultrasound), biochemical markers of congestion: CA125 and NT-proBNP—

Secondary

MeasureTime frame
other measures of interest, Increased diuresis: 24-hour urine volume, 24-hour urine sodium—

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026